Notice

To schedule your COVID vaccine appointment or for more resources visituwhealth.org/covid

Faculty, UW School of Medicine and Public Health

Nataliya V. Uboha, MD, PhD

  • Medical Oncology

About

Dr. Uboha is an assistant professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. She specializes in gastrointestinal (GI) malignancies.

Languages spoken
  • English
University affiliation
  • Department of Medicine

Practice locations

  • UW Carbone Cancer Center - Medical Oncology
    • 600 Highland Ave. / Madison, WI
    • (608) 265-1700
    • Closed now
    • View hours, services and more
  • UW Carbone Cancer Center - Esophageal Cancer Clinic
    • 600 Highland Ave. / Madison, WI
    • (608) 265-1700
    • Closed now
    • View hours, services and more
  • University Hospital - Hepatobiliary Pancreas Clinic
    • 600 Highland Ave. / Madison, WI
    • (608) 263-7502
    • Closed now
    • View hours, services and more
  • University Hospital - Pancreas Mass Clinic
    • 600 Highland Ave. / Madison, WI
    • (608) 265-7200
    • Closed now
    • View hours, services and more

Education & credentials

Board certifications
  • Internal Medicine
  • Medical Oncology
Medical School
  • Yale University School of Medicine, New Haven, CT
Fellowships
  • Smilow Cancer Hospital at Yale-New Haven Hospital, New Haven, CT
Residencies
  • Yale New Haven Hospital, New Haven, CT

Specialties

Additional conditions and treatments
  • Bile Duct Cancer
  • Colon and Rectal Cancer
  • Esophageal Cancer
  • Gastrointestinal Cancer
  • Stomach Cancer

Research and publications

Her research interests are dedicated to the development of biomarker based early phase clinical trials for patients with GI cancer. Dr. Uboha has received numerous funding awards for her research and is actively engaged in developing clinical trials for patients with GI malignancies. Her background and PhD in molecular biology allows for in-depth understanding of molecular mechanisms underlying tumorigenesis and drug development.